Tiziana Life Sciences (TILS)

 

Latest News

Tiziana announces new data with Foralumab

Tiziana Life Sciences announces new data from animal studies demonstrating the potential of its novel oral therapy with f...

New Data with Foralumab

RNS Number: 2686P Tiziana Life Sciences PLC 16 November 2016 Tiziana Life Sciences PLC ("Tiziana" or the "Company") Tiziana Life Sciences Announces New Data with Foralumab, a Fully Human Anti-CD3 Antibody Being Developed as an Oral Therapy for NASH and Autoimmune Diseases London, 16 November 2016 - Tiziana Life Sciences plc (AIM: TILS, the...

Tiziana CFO awarded options

Tiziana Life Sciences' chief financial officer Tiziano Lazzaretti has been awarded options over 100,000 ordinary shares at a...

Grant of options

RNS Number: 5132O Tiziana Life Sciences PLC 07 November 2016 Tiziana Life Sciences PLC ("Tiziana" or the "Company") Grant of options London, 7 November 2016 - Tiziana Life Sciences plc (AIM: TILS, the "Company"), the clinical stage biotechnology company focused on targeted drugs to treat diseases in oncology and immunology, announces that the remune...

All News

DateHeadlineSource
16-11-16Tiziana announces new data with ForalumabStockMarketWire
16-11-16New Data with ForalumabRNS
07-11-16Tiziana CFO awarded options StockMarketWire
07-11-16Grant of optionsRNS
29-09-16Half-year ReportRNS
15-09-16Confirmation of Capital ReductionRNS
18-08-16Change of Registered OfficeRNS
18-07-16Tiziana acquires a unique bio-repositoryStockMarketWire
18-07-16Tiziana acquires a unique bio-repositoryRNS
30-06-16Result of AGMRNS
29-06-16Issue of EquityRNS
10-06-16Grant of options and realisation bonusRNS
07-06-16Tiziana Life Sciences widens FY pretax lossStockMarketWire
07-06-16Final ResultsRNS
01-06-16Partnership with Cardiff Researchers Wins AwardRNS
19-05-16Journal review of anti - CD3 monoclonal antibodiesRNS
04-05-16Appointment of Dr. Robert EvansRNS
28-04-16Exercise of Warrants & Issue of EquityRNS
04-04-16Tiziana Life Sciences appoints CFOStockMarketWire
04-04-16Chief Financial Officer AppointedRNS
15-03-16Co-Founder and NED Prof Chris McGuigan Passes AwayRNS
16-02-16Second Price Monitoring ExtnRNS
16-02-16Price Monitoring ExtensionRNS
13-01-16Tiziana Life Sciences raises GBP0.7m in CLN issueStockMarketWire
13-01-16Fund raisingRNS
11-01-16Development plans for foralumab & SAB appointmentsRNS
08-01-16Update on Tiziana's Bcl-3 inhibitorRNS
31-12-15How AIM smashed blue chips in 2015Interactive Investor
09-12-15Tiziana appoints COO StockMarketWire
09-12-15Appoints James F. Tripp as Chief Operating OfficerRNS
08-12-15Tiziana Life Sciences raises GBP3.8mStockMarketWire
08-12-15Fund raisingRNS
24-11-15Appointment of Non-Executive DirectorRNS
12-11-15Is It Too Late To Buy 2015 Winners Tiziana Life Sciences PLC (+348%), 4d Pharma PLC (+143%) And Pure Wafer plc (+213%)?Motley Fool
30-10-15Exercise of Warrants & Issue of EquityRNS
30-09-15Half Yearly ReportRNS
28-08-15AIM share consolidations: winners and losersInteractive Investor
30-06-15Tiziana Life Sciences passes AGM resolutionsStockMarketWire
30-06-15Result of AGMRNS
26-06-15Small-cap rockets: Double or quits?Interactive Investor

RSS feeds

  • Editorial news feed for LSE:TILS Editorial
  • Regulatory news feed for LSE:TILS Regulatory